top of page
shutterstock_1933552289.jpg

Get The Facts About Bleu Garde™

Engineering

shutterstock_1218355225.jpg

01.
A Comparison Of Grignard Pure® With Ventilation And Filtration Strategies

This white paper addresses the use of Grignard Pure® as an additional layer of protection against the spread of SARS-CoV-2, working in conjunction with proper air filtration and ventilation strategies. It is authored by former EPA Office of Pesticide Programs Deputy Director, William Jordan, together with three members of Grignard Pure®’s independent engineering advisory team.

Screenshot 2023-10-11 at 5.37.45 PM.png

02.
Case Study: New Amsterdam Theatre Proof-Of-Concept: Distribution And Control Of
Grignard Pure®

This case study details the engineering proof-of-concept conducted at The Disney New Amsterdam Theatre in New York City, in October 2021, which successfully demonstrated the ability of Grignard Pure® to be delivered effectively and expediently throughout the entirety of the interior of the theater.

shutterstock_1489007315.jpg

03.
White Paper: New Amsterdam Theatre Proof-Of-Concept:  Ventilation Studies

This white paper benchmarks the ventilation rates and filtration efficacy inside The Disney New Amsterdam Theatre in New York City, during the engineering proof-of-concept conducted in October 2021.

Bleu Garde Logo Corporate Seal Shield Concept-01.png

Contact:​

info@bleugarde.com

​

Bleu Garde, LLC markets Arresta® and its other regulated products solely in accordance with applicable U.S. Environmental Protection Agency (EPA) registrations and approved labeling. Arresta® (EPA Reg. No. 99121-2) is registered as a virucidal air treatment, air sanitizer and fungistat, including for use in occupied indoor spaces in accordance with its EPA-approved label. Product claims, applications and directions for use are governed by the EPA-approved label. Always read and follow label directions.

LinkedIn Button Light Blue2.png
bottom of page